Holen Sie sich die Stockscreener-App
1.55
0.00%
0.00
Schlusskurs vom Vortag:
$1.55
Offen:
$1.53
24-Stunden-Volumen:
75,502
Relative Volume:
0.10
Marktkapitalisierung:
$47.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.37M
KGV:
-1.4505
EPS:
-1.0686
Netto-Cashflow:
$-34.94M
1W Leistung:
-3.73%
1M Leistung:
-67.37%
6M Leistung:
-30.80%
1J Leistung:
-72.12%
1-Tages-Spanne:
$1.52
$1.56
1-Wochen-Bereich:
$1.47
$1.64
52-Wochen-Spanne:
$1.14
$5.96
Skye Bioscience Inc Stock (SKYE) Company Profile
Firmenname
Skye Bioscience Inc
Sektor
Branche
Telefon
(858) 410-0266
Adresse
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Vergleichen Sie SKYE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
3.32 | 4.40B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.07 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.36 | 189.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2497 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.38 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-15 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-28 | Eingeleitet | William Blair | Outperform |
| 2024-09-30 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-04-12 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten
Skye Bioscience Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Volatility clustering patterns for Skye Bioscience Inc.Trade Exit Report & Safe Entry Zone Identification - newser.com
Price action breakdown for Skye Bioscience Inc.2025 EndofYear Setup & Trade Opportunity Analysis Reports - newser.com
Live market analysis of Skye Bioscience Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Can Skye Bioscience Inc. stock maintain growth trajectoryBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
How Skye Bioscience Inc. stock reacts to inflationary pressuresWeekly Trend Recap & Technical Pattern Based Signals - newser.com
What technical models suggest about Skye Bioscience Inc.’s comeback - newser.com
Will Skye Bioscience Inc. (09R) stock outperform foreign stocksPortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
How to integrate Skye Bioscience Inc. into portfolio analysis toolsJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Is Skye Bioscience Inc. stock a defensive play in 2025Trade Analysis Summary & Short-Term Trading Alerts - newser.com
Is Skye Bioscience Inc. (09R) stock a momentum leaderEarnings Performance Report & Growth Focused Stock Reports - newser.com
Will Skye Bioscience Inc. (09R) stock keep raising dividendsJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
Is Skye Bioscience Inc a good long term investmentCapital Gains Strategies & Rapid Portfolio Investment - earlytimes.in
Regression analysis insights on Skye Bioscience Inc. performanceGDP Growth & Weekly Market Pulse Alerts - newser.com
Is Skye Bioscience Inc. forming a reversal patternOil Prices & Verified Swing Trading Watchlist - newser.com
Is Skye Bioscience Inc. still worth holding after the dipWeekly Market Report & AI Optimized Trade Strategies - newser.com
What analysts say about Skye Bioscience Inc stockSupport Zone Identification & Ride the Trends That Billionaires Follow - earlytimes.in
Will Skye Bioscience Inc. stock deliver consistent dividendsGold Moves & Fast Exit and Entry Strategy Plans - newser.com
Intraday pattern recognizer results for Skye Bioscience Inc.Quarterly Investment Review & Daily Oversold Bounce Ideas - newser.com
How Skye Bioscience Inc. stock performs in weak economy2025 Key Lessons & Free Real-Time Market Sentiment Alerts - newser.com
How Skye Bioscience Inc. stock performs during Fed tightening cyclesRate Hike & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-30 23:45:10 - newser.com
Skye Bioscience (SKYE) Price Target Decreased by 41.90% to 8.89 - MSN
Will Skye Bioscience Inc. (09R) stock announce a stock splitWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
What analysts say about Skye Bioscience Inc 09R stockMarket Sentiment Extremes & Access Risk Ratings for Every Stock - earlytimes.in
Finanzdaten der Skye Bioscience Inc-Aktie (SKYE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Skye Bioscience Inc-Aktie (SKYE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 22 '25 |
Sale |
3.42 |
170,449 |
582,936 |
57,493 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| Diep Tuan Tu | Chief Development Officer |
Nov 18 '24 |
Sale |
4.99 |
19,489 |
97,250 |
82,259 |
| Diep Tuan Tu | Chief Development Officer |
Nov 15 '24 |
Sale |
5.55 |
85 |
472 |
101,748 |
| ARSENAULT KAITLYN | Chief Financial Officer |
Nov 18 '24 |
Sale |
4.99 |
43,206 |
215,598 |
166,342 |
| ARSENAULT KAITLYN | Chief Financial Officer |
Nov 15 '24 |
Sale |
5.55 |
190 |
1,054 |
209,548 |
| DHILLON PUNIT | Chief Executive Officer |
Nov 18 '24 |
Sale |
4.99 |
82,546 |
411,905 |
329,823 |
| DHILLON PUNIT | Chief Executive Officer |
Nov 15 '24 |
Sale |
5.55 |
364 |
2,020 |
412,369 |
| Grayson Paul A. | Director |
Nov 18 '24 |
Sale |
4.99 |
86,244 |
430,358 |
259,701 |
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):